Showing results (101-110 of 253) with videos related to
Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2005
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cellsVeronika Groh, Yongqing Q Li, Daniel Cioca, et al.Virology|March 12, 2002
HIV-1 Vpr does not inhibit CTL-mediated apoptosis of HIV-1 infected cellsDeborah A Lewinsohn, Rebecca Lines, David M Lewinsohn, et al.Transplantation|December 25, 2002
Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interestYoshiki Akatsuka, Eisei Kondo, Hirohumi Taji, et al.The Journal of Experimental Medicine|December 8, 2004
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patientsAdrian F Ochsenbein, Stanley R Riddell, Michele Brown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cellsMichael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.Cancer Immunology Research|September 13, 2014
The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activityMichael Hudecek, Daniel Sommermeyer, Paula L Kosasih, et al.Journal for Immunotherapy of Cancer|December 10, 2020
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumabJoshua R Veatch, Naina Singhi, Brenda Jesernig, et al.Nature Reviews. Clinical Oncology|November 23, 2022
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumoursChristian L Flugel, Robbie G Majzner, Giedre Krenciute, et al.Frontiers in Immunology|January 26, 2024
A chimeric antigen receptor-based cellular safeguard mechanism for selective <i>in vivo</i> depletion of engineered T cellsMortimer Svec, Sarah Dötsch, Linda Warmuth, et al.Pageof 26